The Global Rapid Medical Diagnostic Kits Market Size accounted for USD 19.9 Billion in 2021 and is estimated to garner a market size of USD 26.5 Billion by 2030 rising at a CAGR of 3.3% from 2022 to 2030. The rapid diagnostic test kit is majorly preferred in the detection of infectious diseases and is generally described as a point-of-care (POC) test. It strongly relates to the lateral flow involving immunochromatographic tests for the detection of certain infectious diseases. Growing R&D in producing kits for novel viruses is one of the key rapid medical diagnostics kits market trends bolstering industry growth. Furthermore, rapid medical diagnostic test kits require confirmatory or supplementary testing through a conglomeration of complex laboratory techniques.
Rapid Medical Diagnostic Kits Market Report Key Highlights
- Global rapid medical diagnostic kits market revenue is estimated to reach USD 26.5 Billion by 2030 with a CAGR of 3.3% from 2022 to 2030
- North America rapid medical diagnostic kits market share accounted for over 30% regional shares in 2021
- According to the Our Health in Data Organization, the WHO delivered the Ministry of Health with 40,000 rapid antigen tests for COVID-19 in Jan 2021
- Asia-Pacific rapid medical diagnostic kits market growth will record fastest CAGR from 2022 to 2030
- Based on product segment, over the counter (OTC) kits accounted 54% of the overall market share in 2021
- Growing military involvement propels the rapid medical diagnostic kits market value in coming years.
Global Rapid Medical Diagnostic Kits Market Dynamics
Market Drivers
- Increasing need for rapid detection of disease
- Rising awareness about rapid diagnostic tests
- Growing incidence of chronic disorders
Market Restraints
- Increasing number of product recalls
- Rising preference towards PCR and molecular diagnostics
Market Opportunities
- Growing number of government initiatives
- Surging home diagnostic kits usage
COVID-19 response for rapid medical diagnostic kits market
Testing is a cornerstone for the COVID-19 response, enabling countries to trace the virus and prepare to roll out vaccines once available. Rapid test kits specialized to detect the presence of the virus coupled with trained professionals bolster the demand for the rapid medical diagnostic kits market. The effective testing strategy depends on the portfolio of test types that is well suited to appropriate diagnostic kits available in the commercial markets. Currently, there is a trend in the global market for rapid tests for detection and presence of the virus at the point of care, for faster results available at cheap prices. This is one of the prominent factors considered an asset in to fight against COVID-19. Moreover, with strong supporting test-trace-isolate strategies, appropriate tests conducted by rapid medical diagnostic kits help to identify and confirm new outbreaks, and support outbreaks through investigations by screening, monitoring disease trends, and potentially asymptomatic contacts
Rapid Medical Diagnostic Kits Market Report Coverage
| Market |
Rapid Medical Diagnostic Kits Market |
| Rapid Medical Diagnostic Kits Market Size 2021 |
USD 19.9 Billion |
| Rapid Medical Diagnostic Kits Market Forecast 2030 |
USD 26.5 Billion |
| Rapid Medical Diagnostic Kits Market CAGR During 2022 - 2030 |
3.3% |
| Rapid Medical Diagnostic Kits Market Analysis Period |
2018 - 2030 |
| Rapid Medical Diagnostic Kits Market Base Year |
2021 |
| Rapid Medical Diagnostic Kits Market Forecast Data |
2022 - 2030 |
| Segments Covered |
By Product, By Technology, By Application, By End-Use, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
ACON Laboratories, Inc., Abbott, Artron Laboratories Inc., Alfa Scientific Designs, Inc., Becton Dickinson and Company, BTNX, Inc., bioMérieux SA, Cardinal Health, Bio-Rad Laboratories, Inc., Danaher Corporation, Creative Diagnostics, Meridian Bioscience, Inc. and F. Hoffmann-La Roche AG. |
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Market Dynamics
Partnerships between the companies supported by the government flourish the demand for rapid medical diagnostic kits market. As per the reports by World Health Organization (WHO), Global Fund has offered an initial US$ 50 Mn as Covid-19 response for the utility of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries (LMICs), and enable countries to purchase at least 10 million of the new rapid tests at the fixed price. Agreements between the top pioneers involved in the manufacturing of rapid medical diagnostic test kits bolster the growth of the global market. For instance, agreements between the Bill & Melinda Gates Foundation and test manufacturers Abbott and SD Biosensor create a gateway for innovative tests priced at a maximum of US$ 5 for LMICs. Additionally, the Bill & Melinda Gates Foundation has executed separate volume guarantee agreements with rapid medical diagnostic test kits. This further enhanced to make the kits available in the commercial market at a low price. The rapid medical diagnostic test kit available in LMICs was priced at a maximum of US$ 5 per unit over a period of six months. The kits were specialized to give optimal results within 15-30 minutes rather than hours or days.
High Government Involvement Bolsters the Rapid Medical Diagnostic Kits Market Demand
To overcome the spread of the novel coronavirus, the government has taken several initiatives by introducing several government bodies. One such authorized body is the ACT-Accelerator Diagnostics Pillar. The ACT is co-convened by FIND and the Global Fund, by working closely with WHO and over 30 global health experts partners to accelerate innovation and overcome the technical, financial, and political obstacles to achieving equitable access to effective and timely testing. Such unprecedented global collaboration enhances the development and deployment of the first WHO EUL-approved Ag RDT within eight months of the first identification of the virus. In comparison, it took nearly five years to develop the first rapid diagnostic test kit (RDT) for the Human immunodeficiency virus (HIV). On the other hand, the ACT-Accelerator Diagnostic Pillar aims to facilitate the supply of 500 million tests to LMICs within 12 months. The diagnostic pillar of the ACT-Accelerator focuses on ensuring that everyone who needs the test will get one. Nearly 20 million tests have been procured with the Diagnostics Consortium, ensuring diagnostic access for LMCIs and readiness for test-and-treat implantation in the countries.
Rapid Medical Diagnostic Kits Market Segmentation
The worldwide rapid medical diagnostic kits market is split based on product, technology, application, end-use, and geography.
Rapid Medical Diagnostic Kits Market By Product
- Over the Counter (OTC) Kits
- Professional Kits
Rapid Medical Diagnostic Kits Market By Technology
- Lateral Flow
- Agglutination
- Solid Phase
- Other Technologies
Rapid Medical Diagnostic Kits Market By Application
- Blood Glucose Testing
- Infectious Disease Testing
- Cardio Metabolic Testing
- Pregnancy and Fertility Testing
- Fecal Occult Blood Testing
- Coagulation Testing
- Toxicology Testing
- Lipid Profile Testing
- Others
Rapid Medical Diagnostic Kits Market By End-Use
- Hospitals & Clinics
- Home Care
- Diagnostic Laboratories
Based on product, over-the-counter (OTC) kits holds the majority of the market share for the global rapid medical diagnostic kits market in the past and will continue the same trend in the forthcoming years. Easy availability, simpler to utilize in the "near-patient setting", and cost-effective alternative to laboratory testing are the prominent factors that contribute to the growth of the rapid medical diagnostic kits market globally. Additionally, the lateral flow technology segment will account for remarkable revenue in the forecast period. Low development cost and easy manufacturing of lateral flow assays resulted in the expansion of these tests into several rapid testing applications. Lateral flow technology has gained significant attention in the early detection of COVID-19.
For instance, in March 2020, Ozo Life announced the launching of its new product namely, "OZO COVID-19 Rapid Test Kits" a latex-enhanced lateral flow immunoassay for ensuring testing of novel coronavirus coupled with enhanced sensitivity. Also, rising public and private partnerships for the development of novel lateral flow tests targeting COVID-19 diagnosis spur the segmental growth of the rapid medical diagnostic kits market. Apart from that, based on the application segment, infectious disease testing will record remarkable market share contributing to the growth of the rapid medical diagnostic kits market worldwide. The outbreak of the novel corona virus created lucrative opportunities for rapid diagnostic testing to accelerate COVID-19 detection.
This further bolsters the demand for the global rapid medical diagnostic kits market. Furthermore, the hospital segment holds the maximum market share and will continue a similar trend till the forecast period. Dynamic culture or changes in the healthcare industry resulted in increasing the need for hospitals with enhanced diagnostic services.
Rapid Medical Diagnostic Kits Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
The Middle East & Africa (MEA)
- Gulf Cooperation Council (GCC)
- South Africa
- Rest of the Middle East & Africa
Growth in Prevalence of Chronic Disorders Fuels the North America Rapid Medical Diagnostic Kits Market Share
Based on regions, North America leads the rapid medical diagnostic kits market. Growing healthcare sectors result in the adoption of diagnostic kits to detect various infectious diseases caused due to bacteria and viruses. On the other hand, Asia-Pacific is expected to witness the highest growth rate for the rapid medical diagnostic kits market owing to surging awareness among the healthcare sectors and ever-growing patient population about the rapid medical diagnostic tools.
Rapid Medical Diagnostic Kits Market Players
The global rapid medical diagnostic kits companies profiled in the report include ACON Laboratories, Inc., Abbott, Artron Laboratories Inc., Alfa Scientific Designs, Inc., Becton Dickinson and Company, BTNX, Inc., bioMérieux SA, Cardinal Health, Bio-Rad Laboratories, Inc., Danaher Corporation, Creative Diagnostics, Meridian Bioscience, Inc. and F. Hoffmann-La Roche AG.
CHAPTER 1. Industry Overview of Rapid Medical Diagnostic Kits Market
1.1. Definition and Scope
1.1.1. Definition of Rapid Medical Diagnostic Kits
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Rapid Medical Diagnostic Kits Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Rapid Medical Diagnostic Kits Market By Product
1.2.3. Rapid Medical Diagnostic Kits Market By Technology
1.2.4. Rapid Medical Diagnostic Kits Market By End-Use
1.2.5. Rapid Medical Diagnostic Kits Market By Application
1.2.6. Rapid Medical Diagnostic Kits Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Rapid Medical Diagnostic Kits Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Rapid Medical Diagnostic Kits Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Over the Counter (OTC) Kitsscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Rapid Medical Diagnostic Kits Market By Product
5.1. Introduction
5.2. Rapid Medical Diagnostic Kits Revenue By Product
5.2.1. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast, By Product, 2018-2030
5.2.2. Professional Kits
5.2.2.1. Professional Kits Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Over the Counter (OTC) Kits
5.2.3.1. Over the Counter (OTC) Kits Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Rapid Medical Diagnostic Kits Market By Technology
6.1. Introduction
6.2. Rapid Medical Diagnostic Kits Revenue By Technology
6.2.1. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast, By Technology, 2018-2030
6.2.2. Lateral Flow
6.2.2.1. Lateral Flow Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Agglutination
6.2.3.1. Agglutination Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Solid Phase
6.2.4.1. Solid Phase Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.5. Other Technologies
6.2.5.1. Other Technologies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Rapid Medical Diagnostic Kits Market By End-Use
7.1. Introduction
7.2. Rapid Medical Diagnostic Kits Revenue By End-Use
7.2.1. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
7.2.2. Hospitals & Clinics
7.2.2.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Diagnostic Laboratories
7.2.3.1. Diagnostic Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.4. Home Care
7.2.4.1. Home Care Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. Rapid Medical Diagnostic Kits Market By Application
8.1. Introduction
8.2. Rapid Medical Diagnostic Kits Revenue By Application
8.2.1. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast, By Application, 2018-2030
8.2.2. Coagulation Testing
8.2.2.1. Coagulation Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.3. Cardio metabolic Testing
8.2.3.1. Cardio metabolic Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.4. Infectious Disease Testing
8.2.4.1. Infectious Disease Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.5. Pregnancy and Fertility Testing
8.2.5.1. Pregnancy and Fertility Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.6. Fecal Occult Blood Testing
8.2.6.1. Fecal Occult Blood Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.7. Toxicology Testing
8.2.7.1. Toxicology Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.8. Blood Glucose Testing
8.2.8.1. Blood Glucose Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.9. Lipid Profile Testing
8.2.9.1. Lipid Profile Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.10. Others
8.2.10.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 9. North America Rapid Medical Diagnostic Kits Market By Country
9.1. North America Rapid Medical Diagnostic Kits Market Overview
9.2. U.S.
9.2.1. U.S. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
9.2.2. U.S. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
9.2.3. U.S. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.2.4. U.S. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
9.3. Canada
9.3.1. Canada Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
9.3.2. Canada Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
9.3.3. Canada Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3.4. Canada Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
9.4. North America PEST Analysis
CHAPTER 10. Europe Rapid Medical Diagnostic Kits Market By Country
10.1. Europe Rapid Medical Diagnostic Kits Market Overview
10.2. U.K.
10.2.1. U.K. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
10.2.2. U.K. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.2.3. U.K. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.2.4. U.K. Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
10.3. Germany
10.3.1. Germany Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
10.3.2. Germany Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.3.3. Germany Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3.4. Germany Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
10.4. France
10.4.1. France Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
10.4.2. France Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.4.3. France Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4.4. France Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
10.5. Spain
10.5.1. Spain Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
10.5.2. Spain Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.5.3. Spain Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5.4. Spain Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
10.6. Rest of Europe
10.6.1. Rest of Europe Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
10.6.2. Rest of Europe Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
10.6.3. Rest of Europe Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.6.4. Rest of Europe Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Rapid Medical Diagnostic Kits Market By Country
11.1. Asia Pacific Rapid Medical Diagnostic Kits Market Overview
11.2. China
11.2.1. China Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
11.2.2. China Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.2.3. China Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.2.4. China Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
11.3. Japan
11.3.1. Japan Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
11.3.2. Japan Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.3.3. Japan Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3.4. Japan Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
11.4. India
11.4.1. India Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
11.4.2. India Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.4.3. India Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4.4. India Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
11.5. Australia
11.5.1. Australia Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
11.5.2. Australia Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.5.3. Australia Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5.4. Australia Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
11.6. South Korea
11.6.1. South Korea Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
11.6.2. South Korea Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.6.3. South Korea Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.6.4. South Korea Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
11.7.2. Rest of Asia-Pacific Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
11.7.3. Rest of Asia-Pacific Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.7.4. Rest of Asia-Pacific Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Rapid Medical Diagnostic Kits Market By Country
12.1. Latin America Rapid Medical Diagnostic Kits Market Overview
12.2. Brazil
12.2.1. Brazil Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
12.2.2. Brazil Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
12.2.3. Brazil Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.2.4. Brazil Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
12.3. Mexico
12.3.1. Mexico Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
12.3.2. Mexico Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
12.3.3. Mexico Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.3.4. Mexico Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
12.4. Rest of Latin America
12.4.1. Rest of Latin America Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
12.4.2. Rest of Latin America Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
12.4.3. Rest of Latin America Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.4.4. Rest of Latin America Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Rapid Medical Diagnostic Kits Market By Country
13.1. Middle East & Africa Rapid Medical Diagnostic Kits Market Overview
13.2. GCC
13.2.1. GCC Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
13.2.2. GCC Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
13.2.3. GCC Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.2.4. GCC Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
13.3. South Africa
13.3.1. South Africa Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
13.3.2. South Africa Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
13.3.3. South Africa Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.3.4. South Africa Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Product, 2018-2030
13.4.2. Rest of Middle East & Africa Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Technology, 2018-2030
13.4.3. Rest of Middle East & Africa Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.4.4. Rest of Middle East & Africa Rapid Medical Diagnostic Kits Revenue (USD Billion) and Forecast By Application, 2018-2030
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Rapid Medical Diagnostic Kits Market
14.1. Rapid Medical Diagnostic Kits Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Rapid Medical Diagnostic Kits Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. ACON Laboratories, Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2021
15.1.3.2. ACON Laboratories, Inc. 2021 Rapid Medical Diagnostic Kits Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Abbott
15.3. Artron Laboratories Inc.
15.4. Alfa Scientific Designs, Inc.
15.5. Becton Dickinson and Company
15.6. BTNX, Inc.
15.7. bioMérieux SA
15.8. Cardinal Health
15.9. Bio-Rad Laboratories, Inc.
15.10. Danaher Corporation
15.11. Creative Diagnostics
15.12. Meridian Bioscience, Inc.
15.13. F. Hoffmann-La Roche AG
